LANCASTER, Pa. — Septodont North America, a global leader in dental anesthetics, is proud to announce the launch of Flavalta™ lidocaine hydrochloride 2% with epinephrine 1:100,000, the first and only lidocaine formulation with flavoring agents. Representing Septodont’s most significant dental local anesthetic formulation innovation in more than 25 years, Flavalta™ builds on the trusted clinical performance of lidocaine with a formulation that incorporates flavoring agents.
